Atlas Trials

Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab

Clinical trial NCT01788280 · WITHDRAWN

Trial details

NCT number
NCT01788280
Sponsor
University of Utah
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma Multiforme (GBM)
Start date
2018-01-01
Primary completion
2022-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.